Experimental cell therapy tested for Tough-to-Treat lung cancer
NCT ID NCT07246304
Summary
This early-stage study is testing a new type of cell therapy called TC-D101 CAR-T for people with advanced small cell lung cancer that has come back or stopped responding to standard treatments. The main goal is to find a safe dose and see how well the body tolerates the treatment, while also checking for early signs that it might help control the cancer. The study involves collecting a patient's own immune cells, modifying them in a lab to target the cancer, and then infusing them back into the patient after a brief chemotherapy regimen.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER ( SCLC ) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Jinling Hospital
RECRUITINGNanjing, Jiangsu, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.